← Back to headlines
Corcept Therapeutics (CORT) Gains on FDA Approval Amid Lingering Questions
Corcept Therapeutics Incorporated (CORT) has seen gains following FDA approval for its product, though some questions regarding the company's future prospects reportedly remain.
1 Apr, 09:34 — 1 Apr, 09:34
Sources
Showing 1 of 1 sources
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
Four Arrested for Selling P102 Million in Counterfeit Anti-Cancer Medicine in Makati
just now
Philippines receives diesel shipment from Malaysia
just now
Bulgaria Issues 12,000 Permits for Foreign Tourism Workers in Three Months
12m ago